Brief: Neuronetics Receives 510(K) Clearance For Neurostar Advanced Therapy
12/06/2023 15:15
June 12 (Reuters) - Neuronetics Inc STIM.O :
* NEURONETICS RECEIVES 510(K) CLEARANCE FOR OCD MT CAP FOR
NEUROSTAR ADVANCED THERAPY
Source text for Eikon: ID:nGNX4LLKmw
Further company coverage: STIM.O
(reuters.briefs@thomsonreuters.com)
Recent news on Neuronetics
See all newsNeuronetics Inc reports results for the quarter ended June 30 - Earnings Summary
Neuronetics Q2 revenue beats estimates on Greenbrook clinic strength
Neuronetics Inc expected to post a loss of 12 cents a share - Earnings Preview
Brief: Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Neuronetics Appoints Nir Naor Chief Financial Officer Announces Additional Management Changes